Esnaola, N. F., Chaudhary, U. B., O'Brien, P., Garrett-Mayer, E., Camp, E. R., Thomas, M. B., . . . Marshall, D. T. (2014). Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer.
Chicago-tyylinen lähdeviittausEsnaola, Nestor F., et al. Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed By Selective Capecitabine Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer. 2014.
MLA-viiteEsnaola, Nestor F., et al. Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed By Selective Capecitabine Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer. 2014.